Kevin Tang

Chair of the Board, Member of Compensation and Governance Committees

Kevin Tang is the President of Tang Capital Management, LLC, a life sciences-focused investment company he founded in 2002. Kevin founded Concentra Biosciences, LLC in 2023 and has since served as its Chairman. In 2015, he founded Odonate Therapeutics, Inc. and has since served as its Chairman. From 2014 through its acquisition by Innoviva, Inc. in 2022, Kevin was Chairman of La Jolla Pharmaceutical Company. He co-founded Heron Therapeutics, Inc. in 2013 and served as its Chairman through 2020. From 2009 through its acquisition by Endo Pharmaceuticals, Inc. in 2010, Kevin was a director of Penwest Pharmaceuticals Co. In 2006, he co-founded Ardea Biosciences, Inc. and served as a director through its acquisition by AstraZeneca PLC in 2012. From 2001 to 2008, Kevin served as a director of Trimeris, Inc. From 1993 to 2001, he was a research analyst at Deutsche Banc Alex Brown, Inc., an investment banking firm, and most recently was a Managing Director and head of the firm’s Life Sciences research group. Kevin received a B.S. degree from Duke University.